martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 12, 2026

4 Leveraged ETF Winners of Last Week

View original at finance.yahoo.com
4 Leveraged ETF Winners of Last Week Wall Street offered an upbeat performance last week. State Street SPDR S&P 500 ETF Trust SPY has added about 2.4% last week…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Kalshi traders see a 58% probability that a U.S.-Iran deal is reached by 2027.

    60% confidence
  • Kalshi traders see a 47% probability that a U.S.-Iran agreement is reached by September 2026.

    60% confidence
  • The United States was expecting a response on Friday from Iran on the proposal to end the war.

    60% confidence
  • Q1 earnings estimates have moved higher for 7 of the 16 Zacks sectors: Tech, Energy, Basic Materials, Utilities, Industrials, Retail, and Business Services.

    60% confidence
  • Micron Technology is one of the leading worldwide providers of semiconductor memory solutions.

    60% confidence
  • The labor market is stable rather than strong.

    60% confidence
  • Markets currently expect the Federal Reserve to leave rates unchanged through the remainder of the year as inflation remains elevated and the labor market cools only gradually.

    60% confidence
  • In mid-April 2026, odds that the U.S. and Iran reach a nuclear deal by June were more than 70%.

    60% confidence

Data points we hold from this source

United States Government · population4.3 percent_unemployment_rate
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com